Longxian Lv

5.4k total citations · 3 hit papers
73 papers, 4.0k citations indexed

About

Longxian Lv is a scholar working on Molecular Biology, Food Science and Infectious Diseases. According to data from OpenAlex, Longxian Lv has authored 73 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 22 papers in Food Science and 20 papers in Infectious Diseases. Recurrent topics in Longxian Lv's work include Gut microbiota and health (44 papers), Probiotics and Fermented Foods (22 papers) and Clostridium difficile and Clostridium perfringens research (16 papers). Longxian Lv is often cited by papers focused on Gut microbiota and health (44 papers), Probiotics and Fermented Foods (22 papers) and Clostridium difficile and Clostridium perfringens research (16 papers). Longxian Lv collaborates with scholars based in China, United States and Sweden. Longxian Lv's co-authors include Lanjuan Li, Zongxin Ling, Mingfei Yao, Daiqiong Fang, Baohong Wang, Wenrui Wu, Ding Shi, Jianzhong Ye, Liya Yang and Xiaoyuan Bian and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and PLoS ONE.

In The Last Decade

Longxian Lv

72 papers receiving 3.9k citations

Hit Papers

The Human Microbiota in Health and Disease 2017 2026 2020 2023 2017 2019 2021 100 200 300 400 500

Peers

Longxian Lv
Ding Shi China
Longxian Lv
Citations per year, relative to Longxian Lv Longxian Lv (= 1×) peers Ding Shi

Countries citing papers authored by Longxian Lv

Since Specialization
Citations

This map shows the geographic impact of Longxian Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longxian Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longxian Lv more than expected).

Fields of papers citing papers by Longxian Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longxian Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longxian Lv. The network helps show where Longxian Lv may publish in the future.

Co-authorship network of co-authors of Longxian Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Longxian Lv. A scholar is included among the top collaborators of Longxian Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longxian Lv. Longxian Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Longxian, et al.. (2024). Faecal hsa-miR-7704 inhibits the growth and adhesion of Bifidobacterium longum by suppressing ProB and aggravates hepatic encephalopathy. npj Biofilms and Microbiomes. 10(1). 13–13. 2 indexed citations
2.
Shen, Jian, Shuting Wang, Xia He, et al.. (2023). Akkermansia muciniphilaattenuated lipopolysaccharide-induced acute lung injury by modulating the gut microbiota and SCFAs in mice. Food & Function. 14(23). 10401–10417. 38 indexed citations
3.
Xia, Jiafeng, Longxian Lv, Boqiang Liu, et al.. (2022). Akkermansia muciniphila Ameliorates Acetaminophen-Induced Liver Injury by Regulating Gut Microbial Composition and Metabolism. Microbiology Spectrum. 10(1). e0159621–e0159621. 121 indexed citations
4.
Wang, Kaicen, Wenrui Wu, Xianwan Jiang, et al.. (2022). Multi-Omics Analysis Reveals the Protection of Gasdermin D in Concanavalin A-Induced Autoimmune Hepatitis. Microbiology Spectrum. 10(5). e0171722–e0171722. 18 indexed citations
5.
Gu, Yifeng, Yang Wang, Lei Hu, et al.. (2022). Gut Mycobiome in Patients With Chronic Kidney Disease Was Altered and Associated With Immunological Profiles. Frontiers in Immunology. 13. 843695–843695. 18 indexed citations
6.
Xia, Jiafeng, Shiman Jiang, Longxian Lv, et al.. (2021). Modulation of the immune response and metabolism in germ-free rats colonized by the probiotic Lactobacillus salivarius LI01. Applied Microbiology and Biotechnology. 105(4). 1629–1645. 27 indexed citations
7.
Jiang, Shiman, Lingzhi Cai, Longxian Lv, & Lanjuan Li. (2021). Pediococcus pentosaceus, a future additive or probiotic candidate. Microbial Cell Factories. 20(1). 45–45. 137 indexed citations
8.
Han, Shengyi, Yanmeng Lu, Jiaojiao Xie, et al.. (2021). Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey. Frontiers in Cellular and Infection Microbiology. 11. 609722–609722. 267 indexed citations breakdown →
9.
Lv, Longxian, Huiyong Jiang, Xiaoxiao Chen, et al.. (2021). The Salivary Microbiota of Patients With Primary Biliary Cholangitis Is Distinctive and Pathogenic. Frontiers in Immunology. 12. 713647–713647. 14 indexed citations
10.
Liu, Fengping, Nan Zhang, Jiang Peng, et al.. (2020). Characteristics of the urinary microbiome in kidney stone patients with hypertension. Journal of Translational Medicine. 18(1). 130–130. 36 indexed citations
11.
Wang, Qing, Kaicen Wang, Wenrui Wu, et al.. (2020). Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice. Applied Microbiology and Biotechnology. 104(13). 5915–5928. 62 indexed citations
12.
Wang, Qiangqiang, Longxian Lv, Huiyong Jiang, et al.. (2019). Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in d-galactosamine-treated rats. Applied Microbiology and Biotechnology. 103(23-24). 9673–9686. 39 indexed citations
13.
Li, Yating, Jianzhong Ye, Longxian Lv, et al.. (2019). Pretreatment With Bacillus cereus Preserves Against D-Galactosamine-Induced Liver Injury in a Rat Model. Frontiers in Microbiology. 10. 1751–1751. 19 indexed citations
14.
Bian, Xiaoyuan, Wenrui Wu, Liya Yang, et al.. (2019). Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Frontiers in Microbiology. 10. 2259–2259. 418 indexed citations breakdown →
15.
Li, Yating, Longxian Lv, Jianzhong Ye, et al.. (2018). Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in d-galactosamine-treated rats. Applied Microbiology and Biotechnology. 103(1). 375–393. 52 indexed citations
17.
Liu, Fengping, Longxian Lv, Huiyong Jiang, et al.. (2018). Alterations in the Urinary Microbiota Are Associated With Cesarean Delivery. Frontiers in Microbiology. 9. 2193–2193. 6 indexed citations
18.
Shi, Ding, Longxian Lv, Daiqiong Fang, et al.. (2017). Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats. Scientific Reports. 7(1). 6927–6927. 76 indexed citations
19.
Lv, Longxian, Hongcui Cao, Haifeng Lu, et al.. (2017). Bacterial translocation aggravates CCl4-induced liver cirrhosis by regulating CD4+ T cells in rats. Scientific Reports. 7(1). 40516–40516. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026